Literature DB >> 29985792

Quantitative Apparent Diffusion Coefficient Derived From Diffusion-Weighted Imaging Has the Potential to Avoid Unnecessary MRI-Guided Biopsies of mpMRI-Detected PI-RADS 4 and 5 Lesions.

Stephan H Polanec, Thomas H Helbich, Hubert Bickel, Georg J Wengert, Katja Pinker, Claudio Spick, Paola Clauser, Martin Susani1, Shahrokh Shariat2, Pascal A T Baltzer3.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the potential of diffusion-weighted imaging-derived apparent diffusion coefficient (ADC) measurements to obviate unnecessary biopsies in multiparametric MRI-detected PI-RADS 4 and 5 lesions.
MATERIALS AND METHODS: This retrospective, institutional review board-approved study investigated 101 PI-RADS 4 and 5 prostate lesions (52 malignant, 49 benign) verified by in-bore MRI-guided biopsy in 101 men (mean age, 62.8 years). Two readers, who were not aware of the biopsy results independently and repeatedly measured minimum, mean, and maximum ADC from diffusion-weighted imaging measurements (in line with PI-RADS v2 recommendations) using a 2-dimensional region of interest drawn around the biopsied lesions. Diagnostic performance was evaluated using receiver operating characteristic statistics and reproducibility statistics were calculated.
RESULTS: The best diagnostic performance (overall area under the receiver operating characteristic curve [AUC] R1: 0.801; R2: 0.796 peripheral zone AUC R1:0.814, R2: 0.805; transitional zone AUC R1:0.786, R2:0.779) and the tightest limits of interreader agreement (-8.6% to 9.9%) were found in minimum ADC values. Rule-in and rule-out thresholds for diagnosis of prostate cancer were identified, demonstrating a potential to avoid unnecessary biopsies in 32.7% (16/49).
CONCLUSIONS: Quantitative ADC measurement in multiparametric MRI-detected PI-RADS 4 and 5 lesions has the potential to avoid unnecessary MRI-guided biopsies in up to 33%.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29985792     DOI: 10.1097/RLI.0000000000000498

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  3 in total

1.  Accelerated Segmented Diffusion-Weighted Prostate Imaging for Higher Resolution, Higher Geometric Fidelity, and Multi-b Perfusion Estimation.

Authors:  Pelin Aksit Ciris; Jr-Yuan George Chiou; Daniel I Glazer; Tzu-Cheng Chao; Clare M Tempany-Afdhal; Bruno Madore; Stephan E Maier
Journal:  Invest Radiol       Date:  2019-04       Impact factor: 6.016

2.  The value of the apparent diffusion coefficient value in the Liver Imaging Reporting and Data System (LI-RADS) version 2018.

Authors:  Gehad Ahmad Saleh; Ahmed Abdel Khalek Abdel Razek; Lamiaa Galal El-Serougy; Walaa Shabana; Rihame Abd El-Wahab
Journal:  Pol J Radiol       Date:  2022-01-17

3.  Non-timely clinically applicable ADC ratio in prostate mpMRI: a comparison with fusion biopsy results.

Authors:  Zeno Falaschi; Stefano Tricca; Silvia Attanasio; Michele Billia; Chiara Airoldi; Ilaria Percivale; Simone Bor; Davide Perri; Alessandro Volpe; Alessandro Carriero
Journal:  Abdom Radiol (NY)       Date:  2022-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.